The landscape for weight-loss and diabetes treatment shifted dramatically over the weekend as at least six Indian pharmaceutical companies introduced generic versions of Novo Nordisk A/S’ (NYSE:NVO) b[...]
By using this site, you agree to the storage of cookies on your device for enhanced navigation, site analysis, and The TradingPub's marketing. Data sharing with social media platforms might occur based on the privacy choices you make on those platforms. For specifics, see our Privacy Policy.
